For the Inventor, By the Inventor

Enter assignee name

Denver, CO, United States of America

Cortech, Inc.

USPTO Granted Patents = 40

% Expired Patents = 12.5

CIPO Patents = 1

Trademarks = 1

Forward Citations = 498

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Lyle W Spruce (27 out of 34 patents)

Albert Charles Gyorkos (23 out of 31 patents)

John C Cheronis (13 out of 25 patents)

4. Eric T Whalley (10 out of 12 patents)

5. Val S Goodfellow (7 out of 7 patents)

6. Gary P Kirschenheuter (6 out of 19 patents)

7. James K Blodgett (3 out of 7 patents)

8. Manoj Vinayak Marathe (3 out of 3 patents)

9. Lajos Gera (2 out of 13 patents)

10. Kazuyuki Ohmoto (2 out of 27 patents)

11. John M Stewart (2 out of 18 patents)

12. Kazuhito Kawabata (2 out of 4 patents)

13. Axel H Leimer (2 out of 2 patents)

14. Raymond T Cunningham (2 out of 2 patents)

15. Shadrach R Eubanks (2 out of 3 patents)

Core Competencies:

Serine Protease Inhibitors

Bradykinin Antagonists

Peptoid Compounds

Alpha-Keto Oxadiazoles

Cycloheptane Derivatives

Cysteine Protease Inhibitors

Heterocyclic Compounds

N-Substituted Derivatives

Tripeptoid Analogs

Esters

Aromatic Esters

Cytolytic Compounds

40 patents: Sort by Forward Citations

1. 6777403 - Method and structure for inhibiting activity of serine elastases (2004-08-17),

2. 6656911 - Serine protease inhibitors (2003-12-02),

3. 6656910 - Serine protease inhibitors (2003-12-02),

4. 6608175 - Serine protease inhibitors (2003-08-19),

5. 6548638 - Peptoid and nonpeptoid containing &agr;-keto oxadiazoles as serine protease inhibitors (2003-04-15),

6. 6255453 - Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors (2001-07-03),

7. 6159938 - Serine protease inhibitors comprising .alpha.-keto heterocycles (2000-12-12),

8. 6150334 - Serine protease inhibitors-tripeptoid analogs (2000-11-21),

9. 6100238 - Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as (2000-08-08),

10. 6075120 - Bradykinin antagonist (2000-06-13),

11. 6037325 - Substituted heterocyclic compounds useful as inhibitors of (serine (2000-03-14),

12. 6015791 - Serine protease inhibitors-cycloheptane derivatives (2000-01-18),

13. 6004933 - Cysteine protease inhibitors (1999-12-21),

14. 6001814 - Serine protease inhibitors (1999-12-14),

15. 6001813 - Val-pro containing .alpha.-keto oxadiazoles as serine protease inhibitors (1999-12-14),

Cortech, Inc., based in Denver, Colorado, specializes in the development of innovative therapeutic compounds, focusing on serine protease inhibitors, bradykinin antagonists, and peptoid compounds. The company is dedicated to advancing research in cysteine protease inhibitors and heterocyclic compounds, contributing to the pharmaceutical landscape with novel solutions. Cortech's expertise extends to alpha-keto oxadiazoles, cycloheptane derivatives, and tripeptoid analogs, positioning it as a key player in the biotechnology sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

40 Patents

#33 in Denver, CO

#172 in Colorado

#8,612 in US

#17,031 in the World

Denver, CO, United States of America

Cortech, Inc.

Forward Citations = 498

29 inventors:

Lyle W Spruce (27 out of 34 patents)

Albert Charles Gyorkos (23 out of 31 patents)

John C Cheronis (13 out of 25 patents)

4. Eric T Whalley (10 out of 12 patents)

5. Val S Goodfellow (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…